Volume 10, Number 10—October 2004
West Nile Virus Economic Impact, Louisiana, 2002
|Acute care||12 hospitals with >3 adult patients||119||119||204||204|
|Rehabilitation facilities||Patient's survey||139||19e||204||28|
|Hospital care||6 of 12 hospitals||159f||50||329||103|
|Doctors' visits||Patient's survey||139||119||329||282|
|Rehabilitation facilities||Patient's survey||139||43||204||63|
|Durable equipment||Patient's survey||139||36||204||54|
|Mortality||Louisiana Office of Public Health data||24||NAg||NA||NA|
|Nursing home||Patient survey||139||5||204||7|
aNavailable, number of patients for whom data were available from the indicated source, including cases with zero costs.
bNcost-available, number of patients who incurred costs in that particular category out of all patients for whom data were available.
cNtotal, number of patients who potentially could have incurred costs in the given cost category; for example, the number of all WNV cases in Louisiana, or the number of total central nervous system cases in Louisiana.
dNcost-total is estimated by the methods described in Appendix 1.
eThe cost of inpatient rehabilitation treatment was estimated based on seven patients' charges received from four acute-care hospital-based rehabilitation centers.
fOf the159 patients for whom hospital charges were available from the 12 acute care hospitals, 50 from 6 hospitals incurred costs for outpatient hospital treatment.
- Page created: April 23, 2012
- Page last updated: April 23, 2012
- Page last reviewed: April 23, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)